Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial
Whether octreotide prevents pancreatic fistula following pancreatoduodenectomy is controversial and it is believed to be beneficial in soft glands and normal-sized ducts. The aim of this study is to assess the potential value of octreotide in reducing the incidence of pancreatic fistula, postoperative complications, morbidity and hospital stay in patients with soft pancreas and non-dilated ducts.
A total of 109 patients undergoing elective pancreatoduodenectomy with soft pancreas and non-dilated duct were randomized to octreotide group versus no octreotide—the control group. Surgical steps were standardized and incidences of pancreatic fistula, complications, death and hospital stay were assessed.
There were 55 patients in octreotide group and 54 in the control group. Demographic features and pancreatic duct diameter of the groups were comparable. The rates of clinically significant pancreatic fistulae (grades B and C) were 10.9 and 18.5 % (p = ns), and morbidity was 18 and 29.6 % (p = ns), respectively. Patients who received octreotide resumed oral diet early and had a shorter hospital stay.
This study demonstrated no statistical difference in pancreatic fistulae with the use of octreotide, though there was a trend towards fewer incidences of pancreatic fistulae, morbidity and shorter hospital stay.
ClinicalTrials.gov Identifier: NCT01301222
KeywordsPancreatic fistula Octreotide Pancreaticoduodenectomy Randomized controlled trial
- 1.Yeo CJ, Cameron JL, Sohn TA, K D Lillemoe, H A Pitt, M A Talamini, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications and outcomes. Ann Surg 1997; 226:248–257.PubMedCentralCrossRefPubMedGoogle Scholar
- 13.GurusamyKS, Koti R, FusaiG, Davidson BR. Somatostatin analogues for pancreatic surgery. CochraneDatabase of Systematic Reviews 2013, Issue 4. Art. No.: CD008370.Google Scholar
- 15.Buchler M, Friess H, Klempa I,Hermanek P, Sulkowski U, Becker H, Schafmayer A, Baca I, Lorenz D, Meister R. Role of octreotide in the prevention of postoperative complications following pancreaticresection. Am J Surg1992;163:125–30.Google Scholar
- 16.Pederzoli P, Bassi C, Falconi M,Camboni MG. Efficacy of octreotide in the prevention of complications of elective pancreaticsurgery. Br J Surg1994; 81:265–9.Google Scholar
- 18.Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, Campbell KA, Choti MA. “Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial,” Annals of Surgery 2000; 232(3): 419–429.PubMedCentralCrossRefPubMedGoogle Scholar
- 19.Hesse UJ, De Decker C, Houtmeyers P, Demetter P, Ceelen W, Pattyn P, Troisi R, deHemptinne B. Prospectively randomized trialusing perioperative low-dose octreotide to prevent organ related and general complications after pancreatic surgery and pancreatico-jejunostomy. World Journal of Surgery 2005; 29(10):1325–8.Google Scholar
- 20.Kollmar O, Moussavian MR, Richter S, de Roi P, Maurer CA, Schilling MK. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo controlled trial. European Journal of Surgical Oncology 2008; 34(8):868–75.CrossRefPubMedGoogle Scholar
- 24.Fernández-Cruz L, Chavarría EJ, Taura P, Closa D, López-Boado MA, Ferrer J. Prospective randomized trial of the effect of octreotide onpancreatic juice output after pancreaticoduodenectomy inrelation to histological diagnosis, duct size and leakage. HPB 2013, 15, 392–399.Google Scholar
- 25.Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 36:108–124.Google Scholar
- 26.Fuessl HS, Carolan G, Williams G, Bloom SR. Effect of a long-acting somatostatin analogue (SMS 201–995) on postprandial gastric emptying of 99mTc-tin colloid andmouth-to-caecum transit time in man. Digestion 1987; 36: 101–7.Google Scholar